Sensex
83,516.99 profit arw 74.49 (0.09%)
Nifty
25,470.20 profit arw 8.90 (0.03%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Refresh Captcha
Equity

As on : 03-Jul-2025
Corporate News
03-Jul-2025     09:15

Alembic Pharmaceuticals announces acquisition of Utility Therapeutics

Alembic Pharmaceuticals Inc., wholly owned subsidiary of Alembic Pharmaceuticals has acquired Utility Therapeutics for a consideration of $12 million in staggered manner over period of time, depending on milestones achieved.

Utility Therapeutics is involved in the development and approval of two brand pharmaceutical products for the treatment of urinary tract infections (UTI).

-'Pivya' is an FDA approved product to treat uncomplicated UTIs in the US market.

-'MEC' is a product in development for treatment of the complicated UTIs in the US market.

As a product development company they have minimal turnover in last 3 years.

Powered by Capital Market - Live News

INDIAN INDICES

Sensex

83,516.99 74.49 (0.09%)

Nifty

25,470.20 8.90 (0.03%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

23,887.84 -28.23(-0.12%)